| Literature DB >> 15949612 |
S Damji1, G D Barlow, L Patterson, D Nathwani.
Abstract
To aid the ongoing battle against hospital-acquired infection in the UK, all acute National Health Service (NHS) trusts should have audit data about how dedicated isolation beds within the trust are being used. In a previously published audit, we demonstrated that one-third of patients admitted to a dedicated isolation room in Tayside were not thought to be an infection risk by experienced healthcare staff. Since this audit, Tayside's isolation facilities have moved from a small peripheral 'fever' hospital to a large central teaching hospital site. At the time of this move, and using the above audit data, we designed and implemented a guideline for general practitioners and hospital doctors regarding the admission of patients to an isolation bed. The aim of this study was to compare the use of isolation beds before and after the move to the new facilities, which we anticipated would increase the demand for isolation. The results show that by all three criteria used, the utilization of isolation beds has deteriorated following the move, mainly due to the increased admission of general medical 'boarders' and low-risk infection patients. At a time when hospital-acquired infections are increasing, NHS trusts should ensure that dedicated isolation beds are used appropriately.Entities:
Mesh:
Year: 2005 PMID: 15949612 PMCID: PMC7132430 DOI: 10.1016/j.jhin.2004.11.013
Source DB: PubMed Journal: J Hosp Infect ISSN: 0195-6701 Impact factor: 3.926
Guidelines for the admission of patients to the infection unit
| Suspected/proven enteric infection, e.g. |
| Varicella-zoster virus infection, i.e. chickenpox |
| HIV-positive or ‘high-risk’ patients with respiratory tract infection requiring exclusion of tuberculosis and/or an induced sputum for PCP |
| Suspected/proven pulmonary tuberculosis |
| Patients with other resistant organisms (mostly infection, but some colonization if isolation in the ID unit is requested by the infection control team) at high risk of transmitting to other patients, e.g. a patient with a productive cough and confirmed penicillin-resistant pneumococcal pneumonia |
| Fever within three weeks of travel to an area where there is a risk of viral haemorrhagic fever |
| Herpes-simplex virus and other contagious skin infections (e.g. impetigo), particularly if extensive/severe such as in eczema herpeticum |
| Patients requiring ‘protective’ isolation may be admitted to one of the isolation cubicles if a suitable bed is not available on one of the oncology/haematology wards or if the patient poses a significant risk to other vulnerable patients (e.g. chickenpox or shingles) |
|
|
| Suspected/proven viral or bacterial meningitis/encephalitis |
| Severe community-acquired pneumonia if the respiratory unit is full |
| Skin, soft tissue and bone infections, particularly if |
| Bacterial tonsillitis, particularly if |
| Glandular fever |
| Severe sepsis or septic shock of any cause |
| Extrapulmonary tuberculosis |
| Pyrexia of unknown origin |
|
|
HIV, human immunodeficiency virus; PCP, Pneumocystis carinii pneumonia; ID, infectious diseases.
Ideally these infections should be admitted to one of the negatively pressurized isolation rooms.
Appropriateness and infection status of patients admitted to isolation rooms at Kings Cross and Ninewells Hospitals
| Patients admitted to isolation rooms | ||||||
|---|---|---|---|---|---|---|
| Appropriate admission | Inappropriate admission | Infection risk | Non-infection risk | Infection diagnosis | Non-infection diagnosis | |
| Kings Cross Hospital ( | 216 (90.4%) | 23 (9.6%) | 163 (68.2%) | 76 (31.8%) | 228 (95.4%) | 11 (4.6%) |
| Ninewells Hospital ( | 78 (79.6%) | 20 (20.4%) | 44 (44.9%) | 54 (55.1%) | 81 (82.7%) | 17 (17.3%) |
| 7.26 | 15.93 | 12.96 | ||||
| 0.007 | 0.0001 | 0.003 | ||||
Initial diagnoses of patients admitted to isolation rooms
| Kings Cross Hospital ( | Ninewells Hospital ( | |||||
|---|---|---|---|---|---|---|
| Number of patients | Percentage (95% CI) | Number considered to be an infection risk (% of each diagnosis) | Number of patients | Percentage (95% CI) | Number considered to be an infection risk (% of each diagnosis) | |
| Gastroenteritis | 59 | 24.5 (19.5–30.5) | 59 (100) | 5 | 5.0 (1.5–11.5) | 5 (100) |
| LRTI | 24 | 10.0 (6.5–14.5) | 3 (12.5) | 17 | 17.5 (10.5–26.5) | 3 (17.5) |
| Soft tissue infection | 24 | 10.0 (6.5–14.5) | 13 (54) | 15 | 15.5 (9.0–24.0) | 7 (16) |
| Meningitis | 21 | 9.0 (5.5–13.0) | 21 (100) | 3 | 3.0 (0.5–8.5) | 2 (46.5) |
| HIV+respiratory illness | 17 | 7.0 (4.0–11.0) | 17 (100) | 2 | 2.0 (0.5–7.0) | 2 (100) |
| VZV infection | 16 | 6.5 (4.0–10.5) | 16 (100) | 3 | 3.0 (0.5–8.5) | 3 (100) |
| MRSA infection | 11 | 4.5 (2.5–8.0) | 11 (100) | 9 | 9.0 (4.5–16.5) | 9 (100) |
| General medical diagnoses | 11 | 4.5 (2.5–8.0) | 0 (0) | 16 | 16.5 (9.5–25.0) | 0 (0) |
| UTI+pyelonephritis | 11 | 4.5 (2.5–8.0) | 2 (18) | 8 | 8.0 (3.5–15.5) | 1 (12.5) |
| Febrile traveller | 8 | 3.5 (1.5–6.5) | 5 (62.5) | 2 | 2.0 (0.5–7.0) | 2 (100) |
| Tuberculosis | 6 | 2.5 (1.0–5.5) | 5 (83.5) | 6 | 6.0 (2.5–13.0) | 6 (100) |
| Osteomyelitis/septic arthritis | 6 | 2.5 (1.0–5.5) | 0 (0) | 1 | 1.0 (0–5.5) | 0 (0) |
| Tonsillitis | 4 | 1.5 (0.5–4.0) | 3 (75) | 0 | 0.0 (0–3.5) | 0 (0) |
| HIV+non-respiratory illness | 3 | 1.5 (0.25–3.5) | 1 (33.5) | 2 | 2.0 (0.5–7.0) | 2 (100) |
| Prosthetic device infection | 3 | 1.5 (0.25–3.5) | 1 (33.5) | 1 | 1.0 (0–5.5) | 0 (0) |
| Acute viral hepatitis | 3 | 1.5 (0.25–3.5) | 3 (100) | 1 | 1.0 (0–5.5) | 0 (0) |
| HSV stomatitis | 2 | 0.75 (0.1–3.0) | 2 (100) | 0 | 0.0 (0–3.5) | 0 (0) |
| Pyrexia of unknown origin | 2 | 0.75 (0.1–3.0) | 0 (0) | 4 | 4.0 (1.0–10.0) | 0 (0) |
| Miscellaneous infection | 8 | 3.5 (1.5–6.5) | 1 (12.5) | 3 | 3.0 (0.5–8.5) | 2 (66.5) |
LRTI, lower respiratory tract infection; VZV, Varicella-zoster virus; HSV, herpes simplex virus; UTI, urinary tract infection; MRSA, methicillin-resistant Staphylococcus aureus; HIV, human immunodeficiency virus.